Company page

Psyence Biomedical Ltd.

Psyence Biomedical Ltd. (Ticker: PBM) is a public company operating in the American market. With a market capitalization of approximately $3.22 million, Psyence focuses on the development and commercialization of psychedelic products for therapeutic use. The company aims to leverage advancements in psychedelic science to address mental health challenges.